Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
1.28M
-
Shares change
-
+986K
-
Total reported value, excl. options
-
$7.92M
-
Value change
-
+$6.08M
-
Put/Call ratio
-
0.16
-
Number of buys
-
23
-
Number of sells
-
-4
-
Price
-
$6.17
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q1 2021
35 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q1 2021.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.28M shares
of 30M outstanding shares and own 4.28% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (423K shares), VANGUARD GROUP INC (315K shares), MORGAN STANLEY (100K shares), BlackRock Inc. (81.5K shares), CITADEL ADVISORS LLC (70.4K shares), GEODE CAPITAL MANAGEMENT, LLC (65.2K shares), MARSHALL WACE, LLP (49.1K shares), Compagnie Lombard Odier SCmA (35K shares), Bank of New York Mellon Corp (21.2K shares), and RENAISSANCE TECHNOLOGIES LLC (20.9K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.